Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Adalat CC (nifedipine) Extended Release Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – February 2011

Summary View

 

PRECAUTIONS

Patients with Galactose Intolerance
  • Since this medicinal product contains lactose, patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine
Drug Interactions
  • CYP3A inducers….Azithromycin, although structurally related to the class of macrolide antibiotic is void of CYP3A4 inhibition.
  • Cisapride: Simultaneous administration of cisapride and nifedipine may lead to increased plasma concentrations of nifedipine.

ADVERSE REACTIONS

Urogenital/Reproductive
  • erectile dysfunction (ED)
-
-